Advertisement

Zeitschrift für Ernährungswissenschaft

, Volume 17, Issue 4, pp 248–261 | Cite as

Metabolism of arachidonic acid by platelets: utilization of arachidonic acid by human platelets in presence of linoleic and dihomo-γ-linolenic acids

  • K. C. Srivastava
Originalarbeiten

Summary

In vitro human platelet prostaglandin synthesis has been studied from added radioactive arachidonic acid (i) as function of substrate concentration, (ii) as function of platelet concentration and (iii) as function of pH. Platelets, as in platelet rich plasma when labelled with arachidonic acid, washed and treated with thrombin, released radioactivity mainly from phosphatidylcholine and phosphatidylinositol. The released radioactivity was mostly accounted for by the formation of the previously identified oxygenation products of arachidonic acid. Platelet utilization of arachidonic acid was also studied in presence of linoleic and dihomo-γ-linolenic acids, the two essential fatty acids known for antithrombotic effect. At its high concentrations linoleic acid decreased platelet cyclo-oxygenase activity as seen by a decreased formation of endoperoxides from arachidonic acid. Dihomo-γ-linolenic acid was found to be a mutually competitive substrate with arachidonic acid for the platelet prostaglandin synthetase thus causing reduced utilization of arachidonic acid as shown by measuring the various oxygenation products of arachidonic acid. These two acids were utilized differently by platelet prostaglandin synthetase.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Andreoli, V. M., Eur. J. Pharmacol.4, 404 (1968).CrossRefGoogle Scholar
  2. 2.
    Bang, N. U., R. O. Heidenreich, C. W. Trygstad, Ann. N. Y. Acad. Sci. U.S.A.201, 280 (1970).CrossRefGoogle Scholar
  3. 3.
    Bills, T. K., J. B. Smith, M. J. Silver, Biochim. biophys. Acta424, 303 (1976).CrossRefGoogle Scholar
  4. 4.
    Bygdeman, M., K. Svanborg, B. Samuelsson, Clin. Chim. Acta26, 373 (1969).CrossRefGoogle Scholar
  5. 5.
    Danon, A., M. Heimberg, J. A. Oates, Biochim. biophys. Acta388, 318 (1975).CrossRefGoogle Scholar
  6. 6.
    Deykin, D., R. K. Desser, J. clin. Invest.47, 1590 (1968).CrossRefGoogle Scholar
  7. 7.
    Gréen, K., B. Samuelsson, J. Lipid Res.5, 117 (1964).Google Scholar
  8. 8.
    Hamberg, M., B. Samuelsson, Proc. Nat. Acad. Sci. (U.S.A.)71, 3400 (1974).CrossRefGoogle Scholar
  9. 9.
    Hamberg, M., J. Svensson, B. Samuelsson, Proc. Nat. Acad. Sci. (U.S.A.)72, 2994 (1975).CrossRefGoogle Scholar
  10. 10.
    Hamberg, M., J. Svensson, T. Wakabayashi, B. Samuelsson, Proc. Nat. Acad. Sci. (U.S.A.)71, 345 (1974).CrossRefGoogle Scholar
  11. 11.
    Ho, P. P. K., C. P. Walters, H. R. Sullivan, Prostaglandins12, 951 (1976).CrossRefGoogle Scholar
  12. 12.
    Holman, R, T., In:R. T. Holman (ed.), Progress in the chemistry of fats and other lipids, vol. 9, part 2, p. 275. (Oxford 1968).Google Scholar
  13. 13.
    Honstra, G., Haemostasis2, 21 (1974).Google Scholar
  14. 14.
    Kloeze, J., In:S. Bergström, B. Samuelsson (eds.), Nobel Symposium 2, Prostaglandins, p. 241 (Stockholm 1967).Google Scholar
  15. 15.
    Lagarde, M., A. Gharib, M. Dechavane, Clin. Chim. Acta79, 255 (1977).CrossRefGoogle Scholar
  16. 16.
    Marcus, A. J., H. L. Ullman, L. B. Safier, J. Lipid Res.10, 108 (1969).Google Scholar
  17. 17.
    Nugteren, D. H., E. Hazelhof, Biochim biophys. Acta326, 448 (1973).CrossRefGoogle Scholar
  18. 18.
    Oelz, O., H. W. Seyberth, H. R. Knapp Jr., B. J. Sweetman, J. A. Oates, Biochim. biophys. Acta431, 268 (1976).CrossRefGoogle Scholar
  19. 19.
    Pace-Asciak, C., L. S. Wolfe, Biochim. biophys. Acta218, 539 (1970).CrossRefGoogle Scholar
  20. 20.
    Schoene, N. W., J. M. Iacono, In:B. Samuelsson, R. Paoletti (eds.), Advances in prostaglandin and thromboxane research, vol. 2, p. 763. (New York 1976).Google Scholar
  21. 21.
    Silver, M. J., J. B. Smith, C. M. Ingerman, J. J. Kocsis, Prostaglandins4, 863 (1973).CrossRefGoogle Scholar
  22. 22.
    Smith, J. B., C. M. Ingerman, J. J. Kocsis, M. J. Silver, In:Nordøy, A., L. Jørgensen, H. Prydz (eds.), Proceedings from the IIIrd Tromsø Seminar in Medicine, University of Tromsø, Norway, Lipids and Thrombosis, Thrombosis Res.4, 49 (1974).Google Scholar
  23. 23.
    Smith, J. B., C. M. Ingerman, J. J. Kocsis, M. J. Silver, J. clin. Invest.53, 1468 (1974).CrossRefGoogle Scholar
  24. 24.
    Smith, J. B., A. L. Willis, Brit. J. Pharmac.40, 545P (1970).Google Scholar
  25. 25.
    Smith, J. B., A. L. Willis, Nature New Biol.231, 235 (1971).CrossRefGoogle Scholar
  26. 26.
    Smith, J. B., C. M. Ingerman, M. J. Silver, In:M. J. Silver, J. B. Smith, J. J. Kocsis (eds.), Prostaglandins in hematology, p. 277 (New York 1976).Google Scholar
  27. 27.
    Srivastava, K. C., Z. Anal. Chem. (in press).Google Scholar
  28. 28.
    Thomasson, H. J., Rev. fr. Cps. gras, suppl. Journées d'information sur les corps gras alimentaires,22 (1962).Google Scholar
  29. 29.
    Unger, W. G., I. F. Stamford, A. Bennett, Nature (Lond.)233, 336 (1971).CrossRefGoogle Scholar
  30. 30.
    Vergroesen, A. J., Bibliotheca Nutr. Dieta (Karger, Basel)23, 19 (1976).Google Scholar
  31. 31.
    White, H. L., A. T. Glassman, Prostaglandins,12, 811 (1976).CrossRefGoogle Scholar
  32. 32.
    Willis, A. L., K. Comai, D. C. Kuhn, J. Paulsrud, Prostaglandins,8, 509 (1974).CrossRefGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag 1978

Authors and Affiliations

  • K. C. Srivastava
    • 1
  1. 1.Department of Community Health and Environmental Medicine, School of MedicineOdense UniversityOdense CDenmark

Personalised recommendations